Earnings calendar/DMAC
DiaMedica Therapeutics Inc. (DMAC)
Next report date and post-earnings actuals — standardized metrics from the filed statements. No analyst estimates, no narrative, no price targets.
Pre-earnings
The next report date (from the company's filing cadence) and how the business has been running.
Latest EPS YoY
-5.6%
vs 2025-08-12
Latest revenue YoY
—
How results look so far
Trailing revenue (avg 4Q)
—
Printed quarters
EPS beat rate (4Q)
50%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 11, 2026
EPS beat
EPS actual / est
$-0.19 / $-0.20
+5.4%
Revenue actual / est
— / $13.5M
—
Result
Target reached
EPS vs prior estimate, when one exists
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 8/11/2026 | $-0.20 | $-0.19 | +5.4% | $13.5M | Pending | — |
| 5/12/2026upcoming | $-0.17 | Pending | — | $13.5M | Pending | — |
| 5/6/2026 | $-0.17 | $-0.19 | -11.8% | $13.5M | Pending | — |
| 3/31/2026upcoming | $-0.18 | Pending | — | — | Pending | — |
| 3/30/2026 | $-0.17 | $-0.17 | 0.0% | — | Pending | — |
| 3/23/2026upcoming | $-0.17 | Pending | — | — | Pending | — |
| 3/16/2026upcoming | $-0.17 | Pending | — | — | Pending | — |
| 11/12/2025 | $-0.15 | $-0.17 | -13.3% | — | Pending | — |
| 8/12/2025 | $-0.18 | $-0.18 | 0.0% | — | Pending | — |
| 5/13/2025 | $-0.18 | $-0.18 | 0.0% | — | Pending | — |
| 3/17/2025 | $-0.17 | $-0.18 | -5.9% | — | Pending | — |
| 11/13/2024 | $-0.15 | $-0.15 | 0.0% | — | Pending | — |
| 8/7/2024 | $-0.16 | $-0.13 | +18.8% | — | Pending | — |
| 5/8/2024 | $-0.16 | $-0.14 | +12.5% | — | Pending | — |
| 3/19/2024 | $-0.14 | $-0.14 | 0.0% | — | $30.8M | — |
| 11/13/2023 | $-0.14 | $-0.12 | +14.3% | — | Pending | — |
| 8/14/2023 | $-0.22 | $-0.16 | +27.3% | — | Pending | — |
| 5/15/2023 | $-0.16 | $-0.20 | -25.0% | — | Pending | — |
| 3/28/2023 | $-0.14 | $-0.14 | 0.0% | — | Pending | — |
| 11/9/2022 | $-0.13 | $-0.12 | +7.7% | — | $76,000 | — |
Need DMAC data in your own agent or pipeline?
The earnings data on this page — report dates, filed EPS/revenue actuals and run-rate history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.